Nikhil Lalwani - Mar 23, 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Mar 23, 2025
Transactions value $
-$1,121,658
Form type
4
Date filed
3/25/2025, 04:47 PM
Previous filing
Mar 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$1.12M -17.5K -3.59% $64.26 468K Mar 23, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported.